NEXT

Corporate Counsel

Flexion Therapeutics Hires Its First General Counsel

Flexion Therapeutics Inc. has named Mark Levine as its first general counsel and senior vice president. Levine has more than 20 years of corporate legal experience, having previously served as GC at Minerva Neurosciences Inc., assistant GC at athenahealth Inc., and associate GC at Clinical Data Inc., according to his LinkedIn profile.
3 minute read

Daily Report Online

William Kitchens, Arnall Golden Gregory

As a young lawyer at Arnall Golden Gregory, Bill represented clients in the vegetable oil business and successfully fought requirements that their cream…
5 minute read

Delaware Law Weekly

Stark Upholds Instant Removal of Dozens of Products Cases

A Delaware federal judge has upheld the quick removal of 33 products liability cases from state to federal court, in a blow for plaintiffs who argued the move violated the forum-defendant rule.
4 minute read

New York Law Journal

Shkreli Lawyer: 'Strange' Client Lacked Intent to Defraud

In opening arguments for the securities fraud trial for pharmaceutical executive Martin Shkreli, his attorney called on jurors to keep an “open mind” to weigh accusations against a defendant that they may find detestable.
3 minute read

The Recorder

Oregon Prescription Drug Monitoring Program v. U.S. Drug Enforcement Administration

9th Cir.; 14-35402 The court of appeals reversed a judgment. The court held that intervenors needed to establish Article III standing in order to assert…
2 minute read

New York Law Journal

Seated Jury Remains Elusive in Shkreli Securities Fraud Trial

The second day of what at times appeared to provide catharsis for prospective jurors against pharmaceutical executive Martin Shkreli ended on Tuesday without a jury in the securities fraud case.
3 minute read

New York Law Journal

Feds' Win on Motion Over Proof of Intent Deals Setback to Shkreli

The securities fraud trial against pharmaceutical executive Martin Shkreli got off to a rough start for the so-called Pharma Bro on Monday after the judge in the case granted the prosecutors' motion to preclude arguments that he did not intend to defraud investors.
3 minute read

Delaware Business Court Insider

Attorney Pushes Removal Before Service Argument in Eliquis Dispute

An attorney representing plaintiffs in consumer lawsuits against Bristol-Myers Squibb and Pfizer Inc. is contesting the drugmakers' quick removal of the cases from state to federal court, setting the stage for a showdown over an issue that has divided federal judges and created a rift on Delaware's district court.
5 minute read

Corporate Counsel

China, India Lead as Biggest Producers of Counterfeit Goods, Study Shows

More of the world's counterfeit goods are produced in China than in any other country—though India leads the way in counterfeit pharmaceuticals—according to a new report.
3 minute read

National Law Journal

Drugmaker Brandishes 'Bristol-Myers' in Bid to Quell Suits Over Chemo Drug

Sanofi-Aventis U.S. LLC is brandishing a recent U.S. Supreme Court decision to take aim at nearly 70 women who have filed lawsuits over its chemotherapy drug Taxotere.
4 minute read

Resources

  • Why Embracing Change Is Essential for Your Legal Department

    Brought to you by DiliTrust

    Download Now

  • International Export and Trade Assistance State Law Survey

    Brought to you by LexisNexis®

    Download Now

  • How This Personal Injury Firm Reduced Client Intake Time by 80%

    Brought to you by PracticePanther

    Download Now

  • The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation

    Brought to you by Erase.com

    Download Now